Overall, ectopic induction of p16Ink4A in cancer cells inhibits cell growth and induces apoptosis and senescence, whereas CDKN2A silencing reduces the p53-mediated response to chemotherapeutic agents [16]. This evidence concerns the gene CDKN2A and cancer.